Mi Kwon

3.8k total citations
113 papers, 1.1k citations indexed

About

Mi Kwon is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Mi Kwon has authored 113 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Hematology, 44 papers in Oncology and 21 papers in Immunology. Recurrent topics in Mi Kwon's work include Hematopoietic Stem Cell Transplantation (55 papers), Acute Myeloid Leukemia Research (21 papers) and CAR-T cell therapy research (21 papers). Mi Kwon is often cited by papers focused on Hematopoietic Stem Cell Transplantation (55 papers), Acute Myeloid Leukemia Research (21 papers) and CAR-T cell therapy research (21 papers). Mi Kwon collaborates with scholars based in Spain, United States and Germany. Mi Kwon's co-authors include José L. Díez‐Martín, Ismael Buño, Javier Anguita, Carolina Martínez‐Laperche, Pascual Balsalobre, David Serrano, Jorge Gayoso, Rebeca Bailén, Ana Pérez‐Corral and Nieves Dorado and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Annals of Internal Medicine.

In The Last Decade

Mi Kwon

96 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mi Kwon Spain	19	547	376	218	158	154	113	1.1k
Usama Gergis United States	18	538 1.0×	427 1.1×	141 0.6×	198 1.3×	100 0.6×	112	975
Catherine Paillard France	19	390 0.7×	237 0.6×	243 1.1×	129 0.8×	153 1.0×	68	973
S Andresen United States	19	620 1.1×	442 1.2×	201 0.9×	145 0.9×	99 0.6×	35	998
Brian G. Engelhardt United States	19	645 1.2×	208 0.6×	325 1.5×	115 0.7×	208 1.4×	68	1.1k
Rémy Duléry France	17	489 0.9×	346 0.9×	196 0.9×	187 1.2×	100 0.6×	89	935
Arjun Law Canada	17	619 1.1×	391 1.0×	275 1.3×	119 0.8×	201 1.3×	142	1.0k
Monzr M. Al Malki United States	18	761 1.4×	322 0.9×	313 1.4×	178 1.1×	217 1.4×	113	1.2k
Xavier Poiré Belgium	17	505 0.9×	401 1.1×	186 0.9×	197 1.2×	184 1.2×	69	971
Pierre Péterlin France	18	670 1.2×	347 0.9×	313 1.4×	170 1.1×	128 0.8×	108	1.0k
David Michonneau France	20	439 0.8×	268 0.7×	421 1.9×	279 1.8×	75 0.5×	82	1.2k

Countries citing papers authored by Mi Kwon

Since Specialization

Citations

This map shows the geographic impact of Mi Kwon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mi Kwon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mi Kwon more than expected).

Fields of papers citing papers by Mi Kwon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mi Kwon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mi Kwon. The network helps show where Mi Kwon may publish in the future.

Co-authorship network of co-authors of Mi Kwon

This figure shows the co-authorship network connecting the top 25 collaborators of Mi Kwon. A scholar is included among the top collaborators of Mi Kwon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mi Kwon. Mi Kwon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sanz, Jaime, Myriam Labopin, Jurjen Versluis, et al.. (2025). Cytogenetic and molecular risk-driven conditioning intensity in acute myeloid leukemia patients undergoing stem cell transplantation with post-transplant cyclophosphamide: a study from the acute leukemia working party of the EBMT. Bone Marrow Transplantation. 60(4). 529–534.

Camacho-Arteaga, Lina, Gloria Iacoboni, Mi Kwon, et al.. (2025). Late Adverse Events After Chimeric Antigen Receptor T-Cell Therapy for Patients With Aggressive B-Cell Non-Hodgkin Lymphoma. JAMA Network Open. 8(2). e2461683–e2461683.

Bastos‐Oreiro, Mariana, Gloria Iacoboni, Vı́ctor Navarro, et al.. (2025). Chimeric antigen receptor T‐cell therapy outcomes in T cell/histiocyte‐rich large B‐cell lymphoma and subsequent treatment strategies after disease progression: A GELTAMO/GETH study. HemaSphere. 9(2). e70077–e70077. 1 indexed citations

Kim, Do Hyun, Mi Kwon, Sun Hwa Park, et al.. (2024). The Development of a Human Respiratory Mucosa-on-a-Chip Using Human Turbinate-Derived Mesenchymal Stem Cells. Medicina. 60(11). 1741–1741.

Bailén, Rebeca, Juan Carlos Triviño, Javier Anguita, et al.. (2024). Identification of predictive models including polymorphisms in cytokines genes and clinical variables associated with post-transplant complications after identical HLA-allogeneic stem cell transplantation. Frontiers in Immunology. 15. 1396284–1396284.

Choe, Hannah, Amandeep Salhotra, Nosha Farhadfar, et al.. (2024). Dynamics of Overall and Organ-Specific Responses to Axatilimab in Chronic Graft-Versus-Host Disease: Analysis from the Agave-201 Study. Blood. 144(Supplement 1). 98–98.

Kwon, Mi, et al.. (2024). Financial toxicity in allogeneic haematopoietic stem cell transplant patients from a social determinants of health perspective. European Journal of Oncology Nursing. 70. 102584–102584. 2 indexed citations

Nagler, Arnon, Myriam Labopin, Didier Blaise, et al.. (2024). Young (<35 years) haploidentical versus old (≥35 years) mismatched unrelated donors and vice versa for allogeneic stem cell transplantation with post-transplant cyclophosphamide in patients with acute myeloid leukemia in first remission: a study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Bone Marrow Transplantation. 59(11). 1552–1562. 5 indexed citations

Gómez‐Centurión, Ignacio, Anabelle Chinea, Alexandra Pedraza, et al.. (2024). Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease after Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide: A Study on Behalf of the Spanish Hematopoietic Stem Cell Transplantation and Cellular Therapy Group (GETH). Transplantation and Cellular Therapy. 30(9). 914.e1–914.e8.

10.

Gómez‐Centurión, Ignacio, Rebeca Bailén, Diego Carbonell, et al.. (2023). Poor graft function after haploidentical stem cell transplantation with post-transplant cyclophosphamide. Annals of Hematology. 102(6). 1561–1567. 6 indexed citations

11.

Labopin, Myriam, Johanna Tischer, Anna Maria Raiola, et al.. (2023). Second haploidentical stem cell transplantation (HAPLO-SCT2) after relapse from a first HAPLO-SCT in acute leukaemia—a study on behalf of the Acute Leukaemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplantation. 58(8). 907–915. 5 indexed citations

12.

Morgades, Mireia, Carlos Pinho Vaz, Rebeca Bailén, et al.. (2023). Prognosis of patients with acute lymphoblastic leukaemia relapsing after allogeneic stem cell transplantation. European Journal Of Haematology. 110(6). 659–668. 4 indexed citations

13.

Perea, José Ramón Azanza, José Mensa, José Barberán, et al.. (2023). Recommendations on the use of azole antifungals in hematology-oncology patients. Revista Española de Quimioterapia. 36(3). 236–258. 20 indexed citations

14.

Gómez‐Centurión, Ignacio, Rebeca Bailén, Mariana Bastos‐Oreiro, et al.. (2022). Hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS) following treatment with tisagenlecleucel. SHILAP Revista de lepidopterología. 10(1). 101–112. 26 indexed citations

15.

Gómez‐Centurión, Ignacio, M. C. Garcı́a, Eva González-Haba, et al.. (2021). Implementation of a hospital-at-home (HAH) unit for hematological patients during the COVID-19 pandemic: safety and feasibility. International Journal of Hematology. 115(1). 61–68. 12 indexed citations

16.

Iacoboni, Gloria, Kai Rejeski, Annalisa Chiappella, et al.. (2021). Real-World Evidence of Brexucabtagene Autoleucel for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma. Blood. 138(Supplement 1). 2827–2827. 7 indexed citations

17.

González, Marino, Roberto Nuño-Solínis, Esther Lázaro, et al.. (2021). Hospital and outpatient models for Hematopoietic Stem Cell Transplantation: A systematic review of comparative studies for health outcomes, experience of care and costs. PLoS ONE. 16(8). e0254135–e0254135. 15 indexed citations

18.

Dorado, Nieves, Rebeca Bailén, David Serrano, et al.. (2019). Successful Treatment of Severe Aspergillosis with Isavuconazole Therapy after Allogeneic Stem Cell Transplantation. Chemotherapy. 64(2). 57–61. 1 indexed citations

19.

Martínez‐Laperche, Carolina, Víctor Noriega, Mi Kwon, et al.. (2014). Achievement of early complete donor chimerism in CD25+-activated leukocytes is a strong predictor of the development of graft-versus-host-disease after stem cell transplantation. Experimental Hematology. 43(1). 4–13.e1. 2 indexed citations

20.

Serrano, David, Pilar Miralles, Pascual Balsalobre, et al.. (2013). Graft-Versus-Tumor Effect After Allogeneic Stem Cell Transplantation in HIV-Positive Patients With High-Risk Hematologic Malignancies. AIDS Research and Human Retroviruses. 29(10). 1340–1345. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact